123 related articles for article (PubMed ID: 8210659)
1. Incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
Drexler HG; Ludwig WD
Recent Results Cancer Res; 1993; 131():53-66. PubMed ID: 8210659
[No Abstract] [Full Text] [Related]
2. Immunophenotypic classification of acute lymphoblastic leukaemia.
Ludwig WD; Raghavachar A; Thiel E
Baillieres Clin Haematol; 1994 Jun; 7(2):235-62. PubMed ID: 7803900
[No Abstract] [Full Text] [Related]
3. Incidence, clinical and laboratory features, and prognostic significance of immunophenotypic subgroups in acute lymphoblastic leukemia: the GEIL experience.
Garand R; Béné MC
Recent Results Cancer Res; 1993; 131():283-95. PubMed ID: 8210647
[No Abstract] [Full Text] [Related]
4. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419
[TBL] [Abstract][Full Text] [Related]
5. CD34 antigen expression in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Azuma E; Umemoto M; Kubo M; Ohta Y; Zhang SL; Komada Y; Ito M; Sakurai M
Cancer; 1991 Mar; 67(6):1565-9. PubMed ID: 1705862
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.
Ludwig WD; Harbott J; Bartram CR; Komischke B; Sperling C; Teichmann JV; Seibt-Jung H; Notter M; Odenwald E; Nehmer A
Recent Results Cancer Res; 1993; 131():269-82. PubMed ID: 8210646
[No Abstract] [Full Text] [Related]
7. Positive CD17 myeloid antigen in acute leukemia expressing lymphoid antigens: abnormal genomic processes in multiphenotypic leukemia or new subtypes within lymphoid leukemia?
Philip PJ; Baudouin F; Sudaka I; Bayle J
Leuk Lymphoma; 1993 Nov; 11(5-6):473-6. PubMed ID: 7907249
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic analysis of acute leukemia.
Traweek ST
Am J Clin Pathol; 1993 Apr; 99(4):504-12. PubMed ID: 8475917
[No Abstract] [Full Text] [Related]
9. Immunophenotyping of acute lymphoblastic leukemia in pediatric patients by three-color flow cytometric analysis.
Tiensiwakul P; Lertlum T; Nuchprayoon I; Seksarn P
Asian Pac J Allergy Immunol; 1999 Mar; 17(1):17-21. PubMed ID: 10403005
[TBL] [Abstract][Full Text] [Related]
10. Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.
Borowitz MJ; Carroll AJ; Shuster JJ; Look AT; Behm FG; Pullen DJ; Land VJ; Steuber P; Crist WM
Recent Results Cancer Res; 1993; 131():257-67. PubMed ID: 8210645
[No Abstract] [Full Text] [Related]
11. Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study.
Larramendy M; el-Rifai W; Saarinen U; Alitalo R; Luomahaara S; Knuutila S
Exp Hematol; 1995 Dec; 23(14):1563-7. PubMed ID: 8542947
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotyping of lymphomas and leukemias in paraffin-embedded tissues.
Perkins SL; Kjeldsberg CR
Am J Clin Pathol; 1993 Apr; 99(4):362-73. PubMed ID: 8475901
[No Abstract] [Full Text] [Related]
13. Acute lymphoblastic leukemia.
Farhi DC; Rosenthal NS
Clin Lab Med; 2000 Mar; 20(1):17-28, vii. PubMed ID: 10702893
[TBL] [Abstract][Full Text] [Related]
14. CD99 (p30/32MIC2) immunoreactivity in the diagnosis of leukemia cutis.
Dorfman DM; Kraus M; Perez-Atayde AR; Barnhill RL; Pinkus GS; Granter SR
Mod Pathol; 1997 Apr; 10(4):283-8. PubMed ID: 9110288
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic findings in acute biphenotypic leukaemia.
Carbonell F; Swansbury J; Min T; Matutes E; Farahat N; Buccheri V; Morilla R; Secker-Walker L; Catovsky D
Leukemia; 1996 Aug; 10(8):1283-7. PubMed ID: 8709632
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic features of childhood and adult acute lymphoblastic leukemia (ALL): experience of the German Multicentre Trials ALL-BFM and GMALL.
Ludwig WD; Reiter A; Löffler H; Gökbuget ; Hoelzer D; Riehm H; Thiel E
Leuk Lymphoma; 1994; 13 Suppl 1():71-6. PubMed ID: 8075585
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
18. [Immunophenotyping of eighty six children with acute lymphoblastic leukemia by three-color flow cytometry].
Wan S; Gong W; Sun X; Xu J; Tian D
Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):83-6. PubMed ID: 12015077
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a myeloperoxidase mRNA(+) acute lymphoblastic leukemia cell line (EU-1/ALL) established from a child with an apparent case of ALL.
Zhou M; Zaki SR; Ragab AH; Findley HW
Leukemia; 1994 Apr; 8(4):659-63. PubMed ID: 8152261
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
